Showing results (461-470 of 1,919) with videos related to
Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|April 2, 2019
Defensin alpha 6 (DEFA6) is a prognostic marker in colorectal cancerDongjun Jeong, Hyeongjoo Kim, Doyeon Kim, et al.Cancer Biomarkers : Section a of Disease Markers|March 26, 2019
Clinical significance of the expression of long non-coding RNA PVT1 in gliomaJiyang Fang, Jianyue HuangCancer Biomarkers : Section a of Disease Markers|September 17, 2019
Increased expression of miR-181d is associated with poor prognosis and tumor progression of gastric cancerZhichun Li, Qingbo Guo, Yugang Lu, et al.Cancer Biomarkers : Section a of Disease Markers|September 17, 2019
MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancerYing Huang, Wenfeng Xiao, Xiuli Jiang, et al.Cancer Biomarkers : Section a of Disease Markers|September 29, 2019
LncRNA SNHG16 promotes epithelial- mesenchymal transition via down-regulation of DKK3 in gastric cancerChunhuan Zhou, Juanjuan Zhao, Juanjuan Liu, et al.Cancer Biomarkers : Section a of Disease Markers|January 25, 2021
An mRNA characterization model predicting survival in patients with invasive breast cancer based on The Cancer Genome Atlas databaseHuayao Li, Chundi Gao, Jing Zhuang, et al.Cancer Biomarkers : Section a of Disease Markers|February 8, 2021
Significant difference of c-type lectin-like receptor 2 between colorectal cancer and polyp subgroupsMeng-Lin Zhang, Wen-Juan Huang, Chen-Xi Yue, et al.Cancer Biomarkers : Section a of Disease Markers|January 10, 2022
Effect of D-mannose on Philadelphia chromosome-positive leukemia cellsSeiichi Okabe, Yuko Tanaka, Akihiko GotohCancer Biomarkers : Section a of Disease Markers|March 22, 2021
miR-125b enhances metastasis and progression of cancer via the TXNIP and HIF1α pathway in pancreatic cancerPengli Wang, Dan Zheng, Hongyang Qi, et al.Cancer Biomarkers : Section a of Disease Markers|September 8, 2011
Expression of hypoxia inducible factor-1 alpha in matched hormone naive and castrate resistant prostate cancer specimensBeatrix Elsberger, Louise Lankston, Clare Orange, et al.Pageof 192